Cellcept and Conjunctivitis exacerbated - a phase IV clinical study of FDA data

Summary:

Conjunctivitis exacerbated is reported as a side effect among people who take Cellcept (mycophenolate mofetil), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Bactrim, and have Humoral immune defect.

The phase IV clinical study analyzes which people have Conjunctivitis exacerbated when taking Cellcept. It is created by eHealthMe based on reports of 41,092 people who have side effects when taking Cellcept from the FDA, and is updated regularly.

What is Cellcept?

Cellcept has active ingredients of mycophenolate mofetil. It is often used in systemic lupus erythematosus. eHealthMe is studying from 41,872 Cellcept users. Check the latest studies of Cellcept.

What is Conjunctivitis exacerbated?

Conjunctivitis exacerbated (bad situation of conjunctivitis) is found to be associated with 1,068 drugs and 426 conditions by eHealthMe. Check the latest studies of Conjunctivitis exacerbated.

On Jul, 14, 2026

41,092 people reported to have side effects when taking Cellcept.
Among them, 34 people (0.08%) have Conjunctivitis exacerbated.

Could Cellcept cause Conjunctivitis exacerbated?

Among these 34 people:

How long have people been on Cellcept when they have Conjunctivitis exacerbated? *

What is the gender of people who have Conjunctivitis exacerbated when taking Cellcept? *

female: 64.71 %
male: 35.29 %

What is the age of people who have Conjunctivitis exacerbated when taking Cellcept? *

What are other drugs people take besides Cellcept? *

What are other side effects people have besides Conjunctivitis exacerbated? *

Urinary Tract Infection: 7 people, 20.59%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 7 people, 20.59%
Diarrhea: 7 people, 20.59%
Nausea (feeling of having an urge to vomit): 6 people, 17.65%
Weakness: 6 people, 17.65%
Fatigue (feeling of tiredness): 6 people, 17.65%
Nail Infection: 6 people, 17.65%
Hypotension (abnormally low blood pressure): 6 people, 17.65%
Nausea And Vomiting: 5 people, 14.71%
Dyspnea (difficult or laboured breathing): 5 people, 14.71%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 6 people, 17.65%
Humoral Immune Defect (impairment of humoral immunity): 6 people, 17.65%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 4 people, 11.76%
Acidosis (build-up of carbon dioxide in the blood): 2 people, 5.88%
Gastric Ulcer (stomach ulcer): 2 people, 5.88%
Osteoporosis (bones weak and more likely to break): 2 people, 5.88%
Ocular Pemphigoid (inflammatory autoimmune disorder characterized by blistering lesions that affect mucous membrane covering of eye): 2 people, 5.88%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 2.94%
Birth Control: 1 person, 2.94%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 1 person, 2.94%

* Approximation only. Some reports may have incomplete information.

Do you take Cellcept and have Conjunctivitis exacerbated?

- Check whether Conjunctivitis exacerbated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cellcept:

Cellcept (41,872 reports)

Browse all side effects of Cellcept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Conjunctivitis exacerbated:

Conjunctivitis exacerbated (1,068 drugs)

Browse all the conditions that are associated with Conjunctivitis exacerbated:

Conjunctivitis exacerbated (426 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mycophenolate mofetil (the active ingredients of Cellcept) and Cellcept (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.